Carmen Leizagoyen

Dr. Carmen Leizagoyen


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 December 2020 in Biomolecules
Verified
Journal Article
Open access
PDF file
TDTriana Delfin
Triana Delfin
MRMartín Rossotti
Martín Rossotti
RARomina Alvez-Rosado
Romina Alvez-Rosado
CLCarmen Leizagoyen
Carmen Leizagoyen
GGGonzalez Gonzalez
Gonzalez Gonzalez
The Zika virus was introduced in Brazil in 2015 and, shortly after, spread all over the Americas. Nowadays, it remains present in more than 80 countries and represents a major threat due to some singularities among other flaviviruses. Due to its easy transmission, high percentage of silent cases, the severity of its associated complications, and the lack of prophylactic methods and effective treatments, it is essential to develop reliable and rapid diagnostic tests for early containment of the infection. Nonstructural protein 1 (NS1), a glycoprotein involved in all flavivirus infections, is secreted since the beginning of the infection into the blood stream and has proven to be a valuable biomarker for the early diagnosis of other flaviviral infections. Here, we describe the development of a highly sensitive nanobody ELISA for the detection of the NS1 protein in serum samples. Nanobodies were selected from a library generated from a llama immunized with Zika NS1 (ZVNS1) by a two-step high-throughput screening geared to identify the most sensitive and specific nanobody pairs. The assay was performed with a sub-ng/mL detection limit in the sera and showed excellent reproducibility and accuracy when validated with serum samples spiked with 0.80, 1.60, or 3.10 ng/mL of ZVNS1. Furthermore, the specificity of the developed ELISA was demonstrated using a panel of flavivirus’ NS1 proteins; this is of extreme relevance in countries endemic for more than one flavivirus. Considering that the nanobody sequences are provided, the assay can be reproduced in any laboratory at low cost, which may help to strengthen the diagnostic capacity of the disease even in low-resource countries.

28 August 2024 in Microbial Pathogenesis
Verified
Journal Article
Closed access
SRSirley Rodríguez
Sirley Rodríguez
AMAna Marandino
Ana Marandino
GTGonzalo Tomás
Gonzalo Tomás
YPYanina Panzera
Yanina Panzera
GWGabriel Luz Wallau
Gabriel Luz Wallau
RPRuben Pérez
Ruben Pérez

8 August 2025 in Pathogens
Verified
Journal Article
Open access
PDF file
AMAna Marandino
Ana Marandino
GTGonzalo Tomás
Gonzalo Tomás
YPYanina Panzera
Yanina Panzera
WWWilliman Williman
Williman Williman
FDFilipe Dezoeei
Filipe Dezoeei
RPRuben Pérez
Ruben Pérez
The highly pathogenic avian influenza H5N1 2.3.4.4b clade virus has caused widespread outbreaks across South America, primarily affecting seabirds, poultry, and marine mammals. The virus likely reached the continent through migratory birds from North America, initially spreading along the Pacific coast before advancing into Atlantic-bordering countries such as Argentina, Uruguay, and Brazil. This study investigated the dynamics of H5N1 strains in Uruguay during outbreaks from February and October 2023. We analyzed an updated South American database, including a newly sequenced viral genome from a royal tern (Thalasseus maximus) collected at the end of the outbreaks. Phylogeographic reconstruction revealed two distinct South American phylogroups comprising Uruguayan strains: one mainly driven by wild birds and poultry, with the royal tern strain clustering with Brazilian isolates, and another primarily associated with marine mammals, displaying adaptive residues in the PB2 protein. In Uruguay, these phylogroups delineate two main transmission routes: (i) an avian-derived pathway originating in Argentina and (ii) a pinniped-derived route from Chile. Brazil, initially colonized via the Argentine route, later emerged as a secondary source for Uruguay. This host-pathway interplay underscores the virus’s cross-species potential and highlights the need for coordinated regional surveillance within a One Health framework to mitigate zoonotic risks.